-
Outrageous News
-
John Mendelson, M.D., Comments on MDMA Study Proposal
-
MDMA Research Update: September 2002 – Terrible News: The Western IRB Approval Withdrawn
-
We received word that the Institutional Review Board (IRB) had approved MAPS MDMA/PTSD study
-
MDMA/PTSD protocol submitted to the Western Institutional Review Board
-
FDA gives final approval to conduct the treatment sessions
-
Conference call with Dr. Mithoefer, Rick Doblin and FDA officials
-
FDA Rejects Our Request
-
Request submitted to FDA to change the location of the treatment sessions
-
FDA Contacted me to say that MAPS MDMA/PTSD Protocol was Approved
-
MDMA Research Update: October 2001
-
Submission to FDA of a Protocol Designed to Study the Use of MDMA
-
A Draft of the MDMA/PTSD Protocol that MAPS has been Working for 2 Years to Develop
-
The US Sentencing Commission Held an Open Hearing Concerning its Proposal to Increase Penalties
-
MAPS convened a protocol design meeting in San Francisco
-
Rick Doblin Outlines MAPS Strategy for the Development of the Therapeutic Use of MDMA
-
MDMA Teleconference